Novo Nordisk's gilded stock yields almost USD 59bn over 20 years
88 percent of Novo Nordisk’s net profits over the past three years have gone back to shareholders, reports CFO Karsten Munk Knudsen.
by CHRISTIAN BUNDGAARD, translated by daniel pedersen
As it turns out, shareholders in Novo Nordisk have made a good investment.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk execs sell out after receiving shares
For subscribers
Leo Pharma introduces bonus program for employees
For subscribers
